PTCE - Pharmacy Times Continuing Education
Back to Home
On-Demand Virtual Symposium

Recent Advances in Omega-3 Fatty Acids to Reduce Risk of ASCVD in Patients With Elevated Triglyceride Levels

Create AccountAlready Registered? Login Here

Release Date

June 21, 2023

Expiration Date

June 22, 2024

Credits

0.75 On-Demand

Topics

Cardiology

This activity was originally broadcast as a live virtual symposium during the 13th annual Directions in Pharmacy® conference series.

Program Description
Elevated triglyceride levels increase cardiovascular (CV) risk in patients with well controlled low-density lipoprotein cholesterol levels and are part of the causal pathway of atherosclerosis. Statins are the current first-line treatment option; however, some patients are unable to tolerate statins or reduce their cholesterol with statin therapy alone. Omega-3 fatty acids are being incorporated into the treatment paradigm to reduce the residual risk in patients treated with statins. Pharmacists must be familiar with the latest clinical trial data, current and emerging treatments, and available omega-3 products to provide patient-specific therapy recommendations and education on reducing atherosclerotic CV disease risk. Through this activity, pharmacists will be equipped to proactively identify patients who may benefit from omega-3 fatty acid therapy to manage high triglyceride levels and effectively reduce atherosclerotic CV disease event risk.

Target Audience: Pharmacists

Type of Activity: Knowledge
Release date: June 21, 2023
Expiration date: June 21, 2024

Time to complete activity: 0.75 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

  • Outline the role of omega-3 fatty acids in reducing atherosclerotic cardiovascular disease (ASCVD) event risk to optimize patient outcomes
  • Articulate differences between commercially available omega-3 fatty acid products
  • Review the latest clinical trial data and evidence-based guidelines, as well as their application to clinical practice for individualized treatment
  • Elaborate on the role of the pharmacist in improving the care and outcomes in patients at high risk for ASCVD events, including providing treatment recommendations and patient education to reduce ASCVD risk
Recent Advances in Omega-3 Fatty Acids to Reduce Risk of ASCVD in Patients With Elevated Triglyceride Levels

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

This activity is supported by an educational grant from Amarin.

What's Included
  • Access your activities anytime, anywhere, with a computer, tablet or smartphone
  • Free access with a PTCE account
  • Pharmacy education designed to improve patient care

Related Content

Applying Value-Based Principles in ATTR-CM Care: Optimizing Identification, Therapy Selection, and Patient AccessFree On-Demand

Applying Value-Based Principles in ATTR-CM Care: Optimizing Identification, Therapy Selection, and Patient Access

From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic ContinuumFree Live Credit

From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic Continuum

A Managed Care Perspective on Hard-to-Control Hypertension: Understanding the Risks and Challenges in Uncontrolled and Resistant HypertensionFree On-Demand

A Managed Care Perspective on Hard-to-Control Hypertension: Understanding the Risks and Challenges in Uncontrolled and Resistant Hypertension

Redefining Value in Transthyretin Amyloidosis Cardiomyopathy Care: Innovations in Diagnosis, Treatment, and AccessFree On-Demand

Redefining Value in Transthyretin Amyloidosis Cardiomyopathy Care: Innovations in Diagnosis, Treatment, and Access

Course

Recent Advances in Omega-3 Fatty Acids to Reduce Risk of ASCVD in Patients With Elevated Triglyceride Levels

Create Account